Sterling Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Sterling Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-752	Closed	-$7.5K	–	3265
2025 Q2	$7.5K	Buy	752 +293	+64%	+$2.36K	﹤0.01%	2296
2025 Q1	$2.74K	Sell	459 -394	-46%	-$2.89K	﹤0.01%	2459
2024 Q4	$6.55K	Buy	853 +762	+837%	+$6.55K	﹤0.01%	2339
2024 Q3	$929	Buy	+91	New	+$1.39K	﹤0.01%	2571

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's ITOS Position: Q3 2025 in Review

Sterling Capital Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 752 shares — an estimated $7.5K sold.

Sterling Capital Management first reported a position in ITOS in Q3 2024 and held it in 4 quarters. The position peaked at $7.5K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Sterling Capital Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Sterling Capital Management sold 752 iTeos Therapeutics shares in Q3 2025, an estimated $7.5K.
Sterling Capital Management first reported a position in iTeos Therapeutics in Q3 2024 and held it in 4 quarters.
Sterling Capital Management's iTeos Therapeutics position peaked at $7.5K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Sterling Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.